期刊文献+

紫杉醇联合表柔比星对中晚期乳腺癌患者的远期疗效与生活质量改善观察 被引量:4

下载PDF
导出
摘要 目的观察紫杉醇联合表柔比星对中晚期乳腺癌患者的远期疗效及对生活质量的改善作用。方法将80例中晚期乳腺癌患者随机分为两组,各40例。对照组给予紫杉醇化疗方案治疗,观察组给予紫杉醇联合表柔比星化疗方案治疗,评价两组的远期疗效及生活质量。结果观察组的2年无进展生存率明显高于对照组,远处转移率及不良反应发生率明显低于对照组,健康调查简表(SF-36)评分明显高于对照组(P<0.05)。结论紫杉醇联合表柔比星治疗中晚期乳腺癌的远期效果良好,能增加患者生存率,提高患者生活质量,故临床应予应用。
出处 《白求恩医学杂志》 2017年第1期66-67,共2页 Journal of Bethune Medical Science
  • 相关文献

参考文献6

二级参考文献58

  • 1燕平,艾淑颖,李志玖,何清华.希罗达联合多西紫杉醇治疗晚期乳腺癌40例临床观察[J].实用癌症杂志,2014,29(3):327-329. 被引量:7
  • 2田薇薇,张中冕,杨家梅.吡柔比星联合紫杉醇新辅助化疗治疗局部晚期乳腺癌[J].中国肿瘤临床与康复,2005,12(4):334-335. 被引量:4
  • 3付静,赵翌.人参皂甙Rg3诱导细胞凋亡作用的研究[J].实用肿瘤杂志,2006,21(2):125-127. 被引量:14
  • 4Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer[J]. N Engl J Med,2010,363(20) :1938-1948. 被引量:1
  • 5Carey LA,Dees EC,Sawyer L, et al. The triple negative para-dox: primary tumor chemosensitivity of breast cancer subtypes[J]. Clin Cancer Res,2007,13(8) :2329-2334. 被引量:1
  • 6Iwata H, Sato N, Masuda N, et al. Docetaxel followed by flu-orouracil/epirubicin/cyclophosphamide as neoadjuvant chemo-therapy for patients with primary breast cancer[J]. Jpn J ClinOncol,2011,41(7) :867-875. 被引量:1
  • 7Warm M, Kates R, Grobe-Onnebrink E, et al. Impact of tumorbiology,particularly triple-negative status,on response to preop-erative sequential, dose-dense epirubicin, cyclophosphamide fol-lowed by docetaxel in breast cancer[J]. Anti cancer Res, 2010,30(10):4251-4259. 被引量:1
  • 8Torrisi R.Balduzzi A’Ghisini R, et al. Tailored preoperative treat-ment of locally advanced triple negative (hormone receptor negativeand Her-2 negative) breast cancer with epirubicin, cisplatin.and infu-sional fluorouracil followed by weekly paclitaxel [J]. Cancer Che-mother Pharmacol,2008,62(4) :667-672. 被引量:1
  • 9Eisenhauer EA, Therasse P, Bogaerts J, et al. New response e-valuation criteria in solid tumours: revised RECIST guideline(version 1. 1) [J]. Eur J Cancer,2009,45(2) :228-247. 被引量:1
  • 10Huober J,von Minckwitz G,Denkert C et al. Effect of neoadju-vant anthracycline taxane-based chemotherapy in different bio-logical breast cancer phenotypes : overall results from the Gepar-Trio study[J]. Breast Cancer Res Treat,2010,124(1) : 133-140. 被引量:1

共引文献110

同被引文献25

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部